To Disclose or Not to Disclose? SDNY Provides Increased Incentives Under Revised Corporate Enforcement and Voluntary Self-Disclosure Program
Federal Circuit Sheds Light on Patent Eligibility for Gene Therapy Patents in Precedential REGENXBIO Decision
Better Late Than Never? FDA Receives Long-Awaited Statutory Fix for Orphan Drug Exclusivity in Recent Appropriations Act
Power plant strategy, capacity market and new gas-fired power plants: What applies now and what companies need to know